Science Explorer Back to mapMap
Discussion
Researcher · Hospital Terrassa · Spain

Miguel de Sousa Dias

Miguel de Sousa Dias publishes mostly in Molecular Biology, Oncology and Genetics, on topics such as Retinal Development and Disorders, BRCA gene mutations in cancer and Retinoids in leukemia and cellular processes.

OpenAlex
World rank
#5,382,088
of 7,710,434 ranked researchers
Rank in Spain
#126,560
of 204,306
Works
18
Citations
461
Citations per work
25.6
h-index
10
i10-index 10Top 76% in Molecular Biology
Miguel de Sousa Dias

What does Miguel de Sousa Dias research?

Miguel de Sousa Dias's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (19%), Engineering (4%).

Everything else: 8 works · 43.6% of their workLife Sciences: 6 works · 33.4% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 33.4% of their workMolecular Biology: 5 works · 27.1% of their workGenetics: 1 works · 6.3% of their workHealth Sciences: 3 works · 18.8% of their workMedicine: 3 works · 18.8% of their workOncology: 1 works · 8.3% of their workPathology and Forensic Medicine: 1 works · 6.3% of their workOphthalmology: 1 works · 4.2% of their workPhysical Sciences: 1 works · 4.2% of their workEngineering: 1 works · 4.2% of their workBiomedical Engineering: 1 works · 4.2% of their workTHEIR WORKMiguel de SousaDias18works
Life Sciences33%Physical Sciences4%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else843.6%
    1. Biochemistry, Genetics and Molecular Biology633.4%
    1. Medicine318.8%
    1. Engineering14.2%
  1. 1Molecular Biology27% of their works
  2. 2Oncology8% of their works
  3. 3Genetics6% of their works
  4. 4Pathology and Forensic Medicine6% of their works
  5. 5Ophthalmology4% of their works
  6. 6Biomedical Engineering4% of their works

Research topics

Which keywords describe Miguel de Sousa Dias's research?

The keywords of their largest research topics: Gene Therapy, Retinitis Pigmentosa, Precision Medicine, Acute Promyelocytic Leukemia, Biodegradable Polymers, BRCA1, BRCA2 and Carbon Dioxide.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Gene Therapy51 topic
  2. Retinitis Pigmentosa51 topic
  3. Precision Medicine42 topics
  4. Acute Promyelocytic Leukemia21 topic
  5. BRCA121 topic
  6. BRCA221 topic
  7. Biodegradable Polymers21 topic
  8. Carbon Dioxide21 topic
  9. Catalysis21 topic
  10. Cetuximab21 topic
  11. Electrochromic21 topic
  12. Glaucoma21 topic
  13. Intraocular Pressure21 topic
  14. KRAS Mutations21 topic
  15. Polylactic Acid21 topic
  16. Retinoic Acid21 topic
  17. Tungsten Oxide21 topic

Where does Miguel de Sousa Dias work?

Miguel de Sousa Dias's main affiliation in the publication record is Hospital Terrassa, Spain.

How many publications and citations does Miguel de Sousa Dias have?

OpenAlex counts 18 works and 461 citations for Miguel de Sousa Dias, an h-index of 10, ranking #5,382,088 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Miguel de Sousa Dias. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.